Search

RELATED LINKS

WeChat

NMPA

 

艾为康

COPYRIGHT © 2018 Jiangsu Ultracare Medical DeviceTechnology Co.,Ltd Powered by : www.300.cn Changzhou  苏ICP备14027667号-1

Home >  News detail

Overview and forecast of the development of Chinese orthopedic implant medical consumables in 2017

Page view
According to the "China Orthopaedic Implant Medical Consumables Market Research and Investment Prospect Research Report (2017 Edition)" published by Limu Information Consulting, China's orthopedic imp

According to the "China Orthopaedic Implant Medical Consumables Market Research and Investment Prospect Research Report (2017 Edition)" published by Limu Information Consulting, China's orthopedic implant medical consumables market is divided into four categories, except for sports medicine products. Classes, spines and joints are the most important orthopedic implant consumables .

Different from the main market share of joint products in the global orthopedic implant consumables market, the largest category of orthopedic implant medical consumables market in China is trauma, with a market share of 32.09% in 2014. This market characteristic is mainly caused by the maturity of the orthopedic implant consumables market in China.

At present, there are about 130 domestic orthopedic implant consumables manufacturers, and no more than 10 incomes exceed 100 million. From the perspective of enterprise scale, China's orthopaedic industry is still at a relatively preliminary stage. At the same time, due to the gap between the prosthetic material, the shape design of the prosthesis, the accuracy of the surgical positioning device, the surface smoothness of the joint, the performance of the bone cement and the treatment of the contact surface with the bone, the products of the domestic manufacturers are mainly concentrated. In trauma and spine products.

Because most of China's medical high-value consumables and orthopedic implant consumables manufacturers are small, the industry competition pattern is relatively scattered. In 2014, the market share of the top four companies in the orthopedic implant consumables industry in China totaled 39.69%. The market share of the top eight companies was 50.04%, and the industry concentration was not high. Although the concentration of orthopedic implant consumables industry in China is not high, the main players in the market have integrated through mergers and acquisitions. Johnson & Johnson officially acquired Cindy in 2012, and in early 2013, Johnson & Johnson and Cynthia's subsidiary in China After the integration, collectively known as DePuySynthes, Stryker acquired Genesis Medical in 2013, Medtronic acquired Kanghui Medical in 2012, and the industry integration trend is obvious, providing opportunities for enterprises with considerable scale in the industry.